High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$41K
$41,869
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
SOPH
S
SOPHiA GENETICS SA
Puylaert Kevin
• Officer • Chief Sales Officer
Sell to Cover
2026-03-31
$14
|
||||||
| SOPH |
SOPHiA GENETICS SA
|
Officer • Chief Sales Officer
Sell to Cover
|
2026-03-31 | $14 | S | Form 4 |
| SOPH |
SOPHiA GENETICS SA
|
CEO
10b5-1 Sell
|
2026-03-19 | $21,410 | S | Form 4 |
| SOPH |
SOPHiA GENETICS SA
|
CFO
Sell to Cover
|
2026-03-19 | $3,705 | S | Form 4 |
|
SOPH
S
SOPHiA GENETICS SA
Menu Philippe
• Officer • Chief Medical Officer
10b5-1 Sell
2026-03-19
$2,913
|
||||||
| SOPH |
SOPHiA GENETICS SA
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-03-19 | $2,913 | S | Form 4 |
| SOPH |
SOPHiA GENETICS SA
|
President
10b5-1 Sell
|
2026-03-19 | $5,671 | S | Form 4 |
|
SOPH
S
SOPHiA GENETICS SA
Puylaert Kevin
• Officer • Chief Sales Officer
Sell to Cover
2026-03-19
$157
|
||||||
| SOPH |
SOPHiA GENETICS SA
|
Officer • Chief Sales Officer
Sell to Cover
|
2026-03-19 | $157 | S | Form 4 |
|
SOPH
S
SOPHiA GENETICS SA
Valente Manuela
• Officer • Chief People Officer
10b5-1 Sell
2026-03-19
$1,818
|
||||||
| SOPH |
SOPHiA GENETICS SA
|
Officer • Chief People Officer
10b5-1 Sell
|
2026-03-19 | $1,818 | S | Form 4 |
|
SOPH
S
SOPHiA GENETICS SA
Van Well Daan
• Officer • Chief Legal Officer
10b5-1 Sell
2026-03-19
$3,274
|
||||||
| SOPH |
SOPHiA GENETICS SA
|
Officer • Chief Legal Officer
10b5-1 Sell
|
2026-03-19 | $3,274 | S | Form 4 |
| SOPH |
SOPHiA GENETICS SA
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-03-19 | $2,907 | S | Form 4 |